BRIEF published on 11/22/2024 at 08:05, 1 day 1 hour ago Alain Nydegger Joins Multitude's Matching Share Plan Investment Fintech Alain Nydegger Multitude Share Plan
BRIEF published on 11/22/2024 at 08:05, 1 day 1 hour ago Multitude P.L.C. Announces Extraordinary General Meeting Extraordinary General Meeting Shareholder Voting Redomiciliation Swiss Articles Of Association Multitude P.L.C.
PRESS RELEASE published on 11/22/2024 at 08:00, 1 day 1 hour ago Addition of Mr Alain Nydegger as an Eligible Participant under the Group’s Matching Share Plan 2025-2028 Multitude P.L.C. announces Mr. Alain Nydegger as an eligible participant in the Matching Share Plan 2025-2028, granting him a loan for acquiring company shares Share Acquisition Alain Nydegger Matching Share Plan Loan Multitude P.L.C.
PRESS RELEASE published on 11/22/2024 at 08:00, 1 day 1 hour ago NOTICE OF EXTRAORDINARY GENERAL MEETING OF MULTITUDE P.L.C. Notice of Extraordinary General Meeting of Multitude P.L.C. to confirm Swiss Articles of Association. Meeting details provided. Shareholder participation instructions included Extraordinary General Meeting Shareholder Swiss Articles Of Association Multitude P.L.C. Meeting Instructions
BRIEF published on 11/15/2024 at 14:47, 7 days 18 hours ago Multitude p.l.c. Allocates Shares to Employees Through Matching Plan Fintech Vesting Matching Share Plan Employee Shares Multitude P.L.C.
PRESS RELEASE published on 11/15/2024 at 14:42, 7 days 18 hours ago Multitude p.l.c. distributes own shares to employees based on matching share plan vesting Multitude p.l.c. distributes own shares to employees based on matching share plan vesting. Employees invest up to 10% of gross salary in Multitude shares with 1:1 matching after 2 years Vesting Digital Lending Matching Share Plan Employee Shares Multitude P.L.C.
BRIEF published on 11/15/2024 at 09:12, 8 days ago Multitude SE Delivers Strong Q3 Performance Profitability Financial Guidance Q3 Results Multitude SE Leadership Change
PRESS RELEASE published on 11/15/2024 at 09:07, 8 days ago Original-Research: Multitude SE (von NuWays AG): Buy Multitude SE reported strong Q3 figures with improved profitability and confirmed FY24 guidance. New CEO announced from FY25. Analyst recommends Buy with a target price of EUR 12.00 Buy Recommendation FY24 Guidance Multitude SE CEO Announcement Q3 Figures
BRIEF published on 11/14/2024 at 08:05, 9 days 1 hour ago Multitude Group Unveils CEO Transition Plan CEO Transition Strategic Growth Multitude Group Antti Kumpulainen Jorma Jokela
BRIEF published on 11/14/2024 at 08:05, 9 days 1 hour ago Multitude Group Reports Strong Growth and CEO Appointment CEO Appointment EBIT Growth Multitude Group Fintech Expansion International Acquisition
Published on 11/22/2024 at 23:55, 9 hours 26 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 51 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 16 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 51 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 15 hours 7 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 28 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 26 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 21 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 14 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
